ESG

Harbor Reflections is a chance to regroup, reflect, and connect. This wrap-up session will highlight key takeaways from the day’s ESG discussions, with time set aside for informal partner meetings and networking. Whether you’re continuing conversations sparked earlier or forging... Read More →

The topics in this session  will explore how non-U.S. startups can successfully raise funds in the U.S. market. Investors and founders will share insights on what U.S. funders look for, strategies to establish investor trust as a non-US company ,... Read More →

The topics in this session include US regulatory environment & alternative pathways (including next steps,  if already achieved US clearance), levels of clinical evidence, economic outcomes. Speakers:  Kristi Nakayama, Veranex Carmen Brown, Proxima Nicolle Cannon, CQG  

The topics in this session will build on the “Value Workshop” to address the process of payment with respect to generating revenue specific to the US market. Speakers: Tonya Dowd, PRIA Tamara Rook, Rubrum Advising

Getting a product into U.S. hospitals goes beyond FDA approval. This session unpacks how Value Analysis Committees (VACs) work, what matters in their decision-making, and how non-U.S. medtech startups can effectively navigate hospital adoption and internal reimbursement pathways. Speakers: Tonya... Read More →

Breaking into U.S. hospital systems means understanding how Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs) influence purchasing decisions. This session explains how these entities operate, what suppliers need to know, and how non-U.S. medtech companies can align with... Read More →

This session will cover a diverse range of topics, including steps to establish a local legal entity, understanding tax implications, contracting with US distributors & hospitals, and recruitment from a legal perspective. The speakers will also provide legal guidance on... Read More →